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In vitro antiviral activities of three flavonoids; fisetin, naringenin and rutin against DENV-2 (NGC strain) 
were evaluated. Inhibitory effects of each compound at the different stages of DENV-2 infection were 
examined using foci forming unit reduction assay (FFURA) and quantitative real-time polymerase chain 
amplification (qRT-PCR). Fisetin, rutin and naringenin showed cytotoxic effects against Vero cells with 
50% cytotoxicity (CC50) values of 247, >1000, and 87 µg/mL, respectively. Fisetin when added to Vero 
cells after virus adsorption inhibited DENV replication with a half maximal inhibition concentration (IC50) 
value of 55 µg/mL and selectivity index (SI) of 4.49. The IC50 value of fisetin was 43.12 µg/mL with 
SI=5.72 when Vero cells were treated for 5 h before virus infection and continuously up to 4 days post-
infection. There was no direct virucidal activity or prophylactic activity of fisetin against DENV-2. Rutin 
and naringenin did not inhibit DENV-2 replication in Vero cells. Naringenin however, exhibited direct 
virucidal activity against DENV-2 with IC50 = 52.64 µg/mL but the SI was <1. The present study suggests 
that among the flavonoids examined, only fisetin showed significant in vitro anti dengue virus 
replication activity. 
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INTRODUCTION 
 
Dengue virus (DENV) belongs to the Flaviviridae family 
which consists of several important human pathogens. 
There are four different DENV genotypes; DENV-1, 
DENV-2, DENV-3 and DENV-4. All four endemic DENV 
genotypes are transmitted by the mosquitoes, Aedes 
agypti or Aedes Albopictus. Most primary DENV 
infections are asymptomatic or manifests as dengue 
fever (DF), a mild febrile illness with some vascular 
leakage tendencies. The severe forms of dengue usually 
occur in secondary infections which could manifest as 
dengue hemorrhagic fever and dengue shock syndrome 
(DHF/DSS) with severe vascular leakage. Currently, 
there is no effective antiviral drug or licensed vaccine 
against dengue. Finding effective antiviral compound(s) 
against  the  virus  is  crucial   as  the  disease  is   rapidly 
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spreading worldwide and causing many deaths. Among 
the different types of compounds and chemical 
derivatives studied for antiviral activities against DENV, 
include those from natural resources such as plant 
extracts and their purified compounds (Jain et al., 2008). 
Plant-derived compounds are desired due to the potential 
of low side effects and their easy accessibility from the 
nature. Among these plant-derived compounds, 
flavonoids have received considerable attentions as 
possible sources of new therapeutics for viral infections 
(Asres et al., 2005; Wang et al., 2006). Flavonoids are 
phenolic compounds found in many plants (Tapas et al., 
2008). There have been many studies reporting the 
beneficial effects of flavonoids on general health such as 
their anti-oxidant activities, anti-tumor activities and also 
their anti-microbial activities (Chukwujekwu et al., 2011; 
Kale et al., 2008; Middleton, 1996; Tim Kushnie et al., 
2005). Antiviral activities for a number of flavonoids have 
also been described against many different viruses (Lyu 
et  al.,  2005;  Arena  et  al.,  2008;  Xu  et  al., 2010). The 
  
 
 
flavonoids have been shown to possess antiviral activities 
against HSV-1, HSV-2, Sindbis virus, parainfluenzavirus-
3 and HCMV (Hayashi et al., 2007; Lyu et al., 2005; 
Orhan et al., 2010; Paredes et al., 2003). A recent study 
reported the potential of flavonoids as antivirals against 
DENV (Muhamad et al., 2010). In the present study, we 
examined the in vitro antiviral activity of the flavonoids, 
fisetin, naringenin and rutin against DENV-2.  
 
 
MATERIALS AND METHODS 
 
Chemicals 
 
Fisetin and naringenin were purchased from Sigma Chemical 
Company (Sigma, St, Louis, USA) and rutin was purchased from 
Indofine Chemical Company (Indofine, NJ, USA). All compounds 
were initially dissolved in dimethyl sulfoxide (DMSO) (Sigma, St, 
Louis, USA) to prepare the stock solution (20 mg/mL) and stored at 
-20°C until needed. To prepare the different concentrations of each 
compound, the stock solution was serially diluted in serum free cell 
culture medium and sterile-filtered using syringe filter with 0.2 µm 
pore size. Fetal bovine serum (FBS) was added to the treatment 
medium to a final concentration of 2% when needed for the 
treatment of the infected cells. 
 
 
Cells and virus 
 
Dengue virus type-2 (DENV-2) New Guinea C strain (NGC) was 
used for the study. Virus was propagated in A. albopictus C6/36 
monolayer cells at 28°C in the presence of 3% CO2 and harvested 
on day 7 post-infection (PI). Virus stock was prepared and titrated 
as previously described (Wong SS et al., 2007) and stored at -70°C 
until needed. 
African green monkey kidney cells (Vero) was used for the foci 
forming unit reduction assay (FFURA). Cells were cultured in 
Eagle’s minimum essential medium (EMEM) containing 10% fetal 
bovine serum (FBS; Gibco, NY, USA) at 37°C in the presence of 
5% CO2. For maintenance medium, serum concentration was 
reduced to 2%. 
 
 
Cytotoxicity assay.  
 
In vitro cytotoxicity of compounds used in the study was determined 
using MTT (3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium 
Bromide) method performed strictly following the manufacturer’s 
protocol and as previously described (Mosmann, 1983). Briefly, 
Vero cells were cultured in 96-well cell culture microplate. Confluent 
cells were treated by increasing concentration of each compound in 
triplicate wells. The final volume of cell culture medium and 
compound in each well was 90 µl. Treated cells were incubated for 
4 days at 37°C. After 4 days, 15 µl of MTT solution (Promega, WI, 
USA) was added to each well. The microplate was kept at 37°C for 
an additional 4 h in a humidified 5% atmosphere. After the 
incubation period, 100 µl of the solublization/stop solution was 
added to each well. The absorbance value of each well was 
measured using a 96-well plate reader (TECAN, Mannendorf, 
Switzerland) at 570 nm. 
 
 
In vitro antiviral assays. 
 
The in vitro antiviral assay was performed using three different 
treatment  conditions. In  the  first  instance,  Vero  cells were plated  
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into 24 wells cell culture microplate. After attaining 80% confluency, 
virus inoculum consisting of 200 FFU DENV-2 was added to each 
well and virus was allowed to absorb to the cells for 1 h at 37°C. 
Unabsorbed viruses were removed by rinsing cells with sterile PBS 
twice. Different concentrations of each compound were mixed with 
1.5% carboxymethylcellulose (CMC) containing cell-growth medium 
supplemented with 2% FBS and the plates were incubated at 37°C 
for 4 days. After 4 days, cells were fixed with 4% paraformaldehyde 
for 20 min and subsequently permeabilized with 1% NP40 solution 
(Sigma, St, Louis, USA) for 10 min at room temperature. Cells were 
washed 3 times with PBS and blocked with 3% skim milk solution 
prepared in PBS, for 2 h at room temperature. Dengue hyper-
immune serum prepared in rabbit, diluted at 1:500 using 1% skim 
milk solution was added to each well. The cells were incubated at 
37°C for 1 h. After incubation, cells were washed 3 times with PBS 
and similarly incubated with goat anti-rabbit IgG conjugated with 
horse-radish peroxidase (HRP) with final concentration of 1:250 in 
1% skim milk solution (Sigma, St. Louis USA). Finally, 3’ di-amino-
benzidine (DAB) peroxidase substrate (Pierce, Illinois USA) was 
added to each well to stain the virus foci (Okuno et al., 1979). Foci 
were counted under a stereomicroscope and expressed as foci-
forming-unit (FFU). Antiviral activities of the compounds were 
determined by calculating the percentage of foci reduction (%RF) 
compared against the controls maintained in parallel using the 
following formula; RF (%) = (C-T) × 100/C, where, C is the mean of 
the number of foci from triplicates treatment without compound 
added and T is the mean of the number of foci from triplicates of 
each treatment measures with the respective compound (Laille et 
al., 1998).  
In a separate study, the effects of prophylactic treatment of cells 
with the compounds prior to DENV infection were examined. Vero 
cells were treated with the different concentrations of each 
compound for 5 h before viral infection. The treatment medium was 
aspirated after 5 h and cells were rinsed twice with sterile PBS and 
then infected with 200 FFU of DENV-2 in the presence of the 
various concentrations of the compounds. The microplate was kept 
at 37°C for 1 h to allow virus adsorption. After virus adsorption, the 
infected cell monolayer was rinsed twice with sterile PBS in order to 
remove the unabsorbed viruses and incubated in 2% FBS 
containing EMEM with 1.5% CMC and the different concentration of 
the compounds. The plates were incubated at 37°C for 4 days in 
the presence of 5% CO2. Viral foci were stained and counted as 
described in the foregoing.  
The potential direct virucidal effects of the compounds on DENV 
were examined by treating virus suspension containing 200 FFU of 
DENV-2 with increasing concentration of each of the compound for 
2 h at 37°C. Vero cell monolayers in 24 wells cell culture microplate 
were infected with the compound-treated virus suspensions. After 1 
h adsorption at 37°C, cells were rinsed twice with PBS to remove 
unabsorbed viruses. Then 1.5% CMC containing growth medium 
was added to each well and the microplate was incubated for 4 
days in a humidified 37°C incubator in the presence of 5% CO2. 
Viral foci staining were performed as described in the foregoing. 
 
  
Quantitative RT-PCR 
 
DENV genome replication was estimated using the quantitative RT-
PCR method described previously with some modifications (Wong 
et al., 2007). Briefly, DENV-2 RNA was extracted from the DENV-2 
infected cells and cell culture supernatant using RNA extraction kit 
(Qiagen, Hilden, Germany). Quantitative RT-PCR was performed 
using SensiMix SYBR green mixture (Quantace, Watford, United 
Kingdom) in a total reaction volume of 20 µl consisting of ddH2O 
(7.4 µl), 2× SensiMix One-Step (10 µl), 50× SYBR Green solution 
(0.4 µl), RNase Inhibitor (10 units), 50 pmol each of forward (DNF) 
and reverse (D2R) primers, and the extracted DENV RNA (1 µl) 
(Seah  et  al.,  1995). All amplifications were performed in triplicates  
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Figure 1. Cytotoxicity of flavonoids against Vero cells. MTT assay was used to evaluate 
the cytotoxicity of the flavonoids. All experiments were conducted in triplicates. 
 
 
 
Table 1. In vitro cytotoxicity effects of flavonoids against Vero cells.  
 
Flavonoid CC50(µg mL-1) 
Fisetin 247 
Rutin >1000 
Naringenin 83 
 
 
 
using the DNA engine opticon system® (MJ Research/Bio-Rad, 
Hercules, CA) and the following amplification cycles: reverse 
transcription at 5°C for 30 min, initial denaturation at 95°C (10 min), 
followed by 45 cycles of 95°C for 15 s, 59°C for 30 s and 72°C for 
30 s. Melting curve analysis was performed at temperature from 60 
to 98°C to verify the assay specificity. For absolute quantitation of 
the viral RNA, a standard curve was established with a serially 
diluted RNA extracted from virus inoculum with known infectious 
virus titer. 
 
 
Statistical analysis 
 
Statistical analysis was performed using Graph Pad Prism for 
Windows, version 5 (Graph Pad Software Inc., San Diego, CA, 
2005). Selectivity index value (SI) was determined as the ratio of 
CC50/IC50 of each compound. 
 
 
RESULTS AND DISCUSSION 
 
Cytotoxicity of bioflavonoids 
 
Potential cytotoxic effects of the compounds were 
determined  using  the  MTT  assays  (Figure  1).  Results 
from the assays suggested that the 50% cytotoxicity 
(CC50) values for fisetin, rutin and naringenin were 247, 
>1000 and 87 µg/mL, respectively (Table 1). Naringenin 
was the most cytotoxic compound to Vero cells among 
the three examined compounds.  
Rutin showed no significant cytotoxicity against Vero 
cells. There were no measurable cytotoxic effects of 
0.5% DMSO against Vero cells examined at the highest 
possible concentration as solvent for the compounds 
used in the study. 
 
 
Antiviral assays with different compounds against 
DENV-2 
 
Foci forming unit reduction assay (FFURA) was used to 
evaluate the in vitro anti-dengue virus activities of the 
flavonoids examined in the study. All the compounds 
were examined (i) for their prophylactic activity (ii) when 
added subsequent to virus infection of cells, (iii) when 
added to cells at 5 h prior to infection and then all 
throughout the assay period and (iv) directly to virus 
suspension to examine their direct virucidal effects.  
    50          100         150         200         250 
 
        Concentration (ug/ml) 
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Figure 2. Assay of flavonoids against DENV-2 intracellular replication. Foci forming unit reduction assay 
(FFURA) was used to evaluate the in vitro anti-dengue virus activities of the tested flavonoids after viral 
adsorption (a) and the respective DENV2 RNA copies were quantified using QRT-PCR (b). All 
experiments were conducted in triplicates. The percentages of foci reduction (%RF) were obtained by 
comparing against the controls maintained in parallel. Data were plotted using Graph Pad Prism Version 
5 (Graph Pad Software Inc., San Diego, CA.). 
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Figure 3. Evaluation of flavonoids continous flavoniods treatment against DENV-2 replication. Foci forming 
unit reduction assay (FFURA) was used to evaluate the in vitro anti-dengue virus activities of the tested 
flavonoids 5 h before infection to 4 days post infection (a) and the respective DENV2 RNA copies were 
quantified using QRT-PCR (b). All experiments were conducted in triplicates. The percentages of foci 
reduction (%RF) were obtained by comparing against the controls maintained in parallel. Data were plotted 
using Graph Pad Prism Version 5 (Graph Pad Software Inc., San Diego, CA.). 
 
 
 
Fisetin showed a dose-dependent inhibition of DENV-2 
replication in the FFURA with a half maximal inhibition 
concentration (IC50) value of 55 µg/mL when added 
subsequent to infection of the Vero cells (Figure 2a). 
Comparable IC50 inhibition value (IC50 = 50 µg/mL) was 
obtained for inhibition of 49% ± 1 DENV-2 genome copy 
number relative to the untreated Vero cell cultures, 
determined  by  qRT-PCR   (Figure  2b).   There   was  no 
significant direct virucidal activity of fisetin against DENV-
2 (Figure 4). Fisetin when continuously present exhibited 
anti-dengue activity with IC50 = 43.12 µg/mL (Figure 3a). 
This finding was supported by the qRT-PCR results 
which showed that the DENV-2 RNA level was 
decreased by more than 65% ± 1.3 when Vero cells were 
similarly treated with 50 µg/mL fisetin (Figure 3b). 
Naringenin  and  rutin  when added to cells subsequent to 
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Figure 4. Direct virucidal activity of flavonoids against DENV-2. Foci forming unit reduction assay (FFURA) was 
used to evaluate the direct anti-dengue virus activities of the tested flavonoids by treatment of viral suspension 
with flavonoids prior to infection (a) and the respective DENV2 RNA copies were quantified using QRT-PCR (b). 
All experiments were conducted in triplicates. The percentages of foci reduction (%RF) were obtained by 
comparing against the controls maintained in parallel. Data were plotted using Graph Pad Prism Version 5 (Graph 
Pad Software Inc., San Diego, CA.). 
 
 
 
DENV-2 infection did not exhibit any anti-DENV-2 
activities (Figure 2). No antiviral activity was also 
recorded when naringenin and rutin was added to cells 
continuously from 5 h before virus infection up to 4 days 
post infection (Figure 3). These findings were 
corroborated by results obtained from qRT-PCR which 
indicated no significant reduction in the amount of total 
DENV-2 genomic RNA levels (Figures 2b and 3b). 
Naringenin, however, exhibited direct virucidal activity 
against DENV-2 with IC50 = 52.64 µg/mL when added 
directly to the virus suspension (Figure 4a). Naringenin at 
50 µg/mL decreased the DENV-2 RNA level by 50% ± 1.3 
when compared to the non treated virus inoculum (Figure 
4b). In an earlier study, it was described that the 
flavonoids, glabranine and 7-O-Methyl-Glabranine 
exhibited significant anti-dengue activity in cell culture 
(Sanchez et al., 2000). It was also described in an in vitro 
study that pinostrobin could inhibit DENV-2 NS2B/NS3 
protease (Kiat et al., 2006).  
Results from the present study suggest that fisetin 
(C15H10O6), a flavonol commonly found in A. greggii, A. 
berlandieri, Gleditschia triacanthos, Quebracho colorado 
and also in mangoes, parrot tree and Euroasian 
smoketree, possesses anti-DENV activities. The anti-
DENV activity is notable when cells were treated 
continuously for 5 h before infection until 4 days post-
infection as well as when added subsequent to virus 
infection. Naringenin (C15H12O5), a plant flavonone found 
in grapefruit, orange and tomato skin, on the other hand, 
showed no inhibition of DENV-2 replication. Naringenin 
however, exerted direct virucidal effects on DENV even 
though it is highly cytotoxic with selectivity index (SI) of 
<1. Rutin (C27H30O16), one of the flavonoid glycosides 
found in buckwheat, asparagus, citrus fruits and some 
berries showed no inhibition of virus adsorption and 
DENV-2 replication as well as no prophylactic effect 
against virus infection. The mechanism of how fisetin 
affects DENV virus replication is unclear.  
Fisetin is not likely to act directly on the virus, as there 
was no inhibition of the virus when fisetin was added 
directly the virus inoculum. These results also suggest 
that fisetin does not affect DENV-2 binding to cells. 
Results from the qRT-PCR assay suggest that fisetin 
could affect DENV genome copy number. One possibility 
is that fisetin could interfere with DENV-2 replication by 
binding directly to virus RNA, forming a flavonoid-RNA 
complex (Nafisi et al., 2009) or affecting the RNA 
polymerases (Ono et al., 1990) resulting in inhibition of 
virus replication. Prophylactic treatment of cells with 
fisetin could result in accumulation of intracellular fisetin, 
which in-turn increases inhibition of dengue virus 
replication. Further study to improve the efficacy of the 
anti-DENV properties of fisetin could be undertaken 
utilizing fisetin as a base molecule for further 
modifications. 
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